Market Closed -
Euronext Bruxelles
11:35:29 2024-05-03 am EDT
|
5-day change
|
1st Jan Change
|
65
EUR
|
+2.52%
|
|
+4.84%
|
-8.96%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
3,379
|
3,291
|
4,448
|
2,697
|
2,623
|
2,388
|
-
|
-
|
Enterprise Value (EV)
1 |
5,092
|
5,525
|
6,996
|
5,558
|
5,348
|
5,186
|
5,032
|
4,945
|
P/E ratio
|
15.7
x
|
27.1
x
|
16
x
|
5.55
x
|
-43.8
x
|
15.4
x
|
9.6
x
|
10.6
x
|
Yield
|
4.27%
|
4.76%
|
4.27%
|
7.41%
|
8.68%
|
9.48%
|
9.43%
|
9.38%
|
Capitalization / Revenue
|
14.5
x
|
13.1
x
|
14.9
x
|
8.27
x
|
7.42
x
|
6.76
x
|
6.57
x
|
6.41
x
|
EV / Revenue
|
21.9
x
|
22
x
|
23.4
x
|
17
x
|
15.1
x
|
14.7
x
|
13.8
x
|
13.3
x
|
EV / EBITDA
|
26.1
x
|
26.1
x
|
28.8
x
|
21.4
x
|
-
|
18.1
x
|
17
x
|
16.3
x
|
EV / FCF
|
30.2
x
|
31.1
x
|
60.1
x
|
58.5
x
|
-
|
22.4
x
|
20.6
x
|
20
x
|
FCF Yield
|
3.31%
|
3.21%
|
1.66%
|
1.71%
|
-
|
4.46%
|
4.86%
|
5%
|
Price to Book
|
1.38
x
|
1.28
x
|
1.38
x
|
0.76
x
|
0.72
x
|
0.68
x
|
0.65
x
|
0.64
x
|
Nbr of stocks (in thousands)
|
25,796
|
27,017
|
31,656
|
32,220
|
36,743
|
36,743
|
-
|
-
|
Reference price
2 |
131.0
|
121.8
|
140.5
|
83.70
|
71.40
|
65.00
|
65.00
|
65.00
|
Announcement Date
|
2/13/20
|
2/25/21
|
2/24/22
|
2/17/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
233
|
251.5
|
299
|
326
|
353.4
|
353.5
|
363.7
|
372.9
|
EBITDA
1 |
194.7
|
212.1
|
242.7
|
260.3
|
-
|
285.9
|
295.7
|
302.8
|
EBIT
1 |
194
|
211.1
|
241
|
257
|
277.7
|
291.9
|
296.8
|
302.8
|
Operating Margin
|
83.26%
|
83.93%
|
80.6%
|
78.83%
|
78.58%
|
82.57%
|
81.62%
|
81.22%
|
Earnings before Tax (EBT)
1 |
215.7
|
125.9
|
275.5
|
494.1
|
-47.99
|
80
|
304
|
-
|
Net income
1 |
205
|
119.2
|
260
|
483
|
-55.5
|
68
|
331.4
|
323.7
|
Net margin
|
87.98%
|
47.4%
|
86.96%
|
148.16%
|
-15.7%
|
19.24%
|
91.12%
|
86.81%
|
EPS
2 |
8.370
|
4.500
|
8.780
|
15.09
|
-1.630
|
4.212
|
6.771
|
6.145
|
Free Cash Flow
1 |
168.7
|
177.6
|
116.4
|
95.01
|
-
|
231.5
|
244.5
|
247.5
|
FCF margin
|
72.41%
|
70.62%
|
38.94%
|
29.14%
|
-
|
65.49%
|
67.23%
|
66.38%
|
FCF Conversion (EBITDA)
|
86.64%
|
83.75%
|
47.96%
|
36.51%
|
-
|
80.97%
|
82.68%
|
81.74%
|
FCF Conversion (Net income)
|
82.3%
|
148.99%
|
44.78%
|
19.67%
|
-
|
340.44%
|
73.78%
|
76.46%
|
Dividend per Share
2 |
5.600
|
5.800
|
6.000
|
6.200
|
6.200
|
6.159
|
6.130
|
6.100
|
Announcement Date
|
2/13/20
|
2/25/21
|
2/24/22
|
2/17/23
|
2/23/24
|
-
|
-
|
-
|
Fiscal Period: December |
2020 S1
|
2021 S1
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
|
125.6
|
141.8
|
82.04
|
76.38
|
78.61
|
80.64
|
90.37
|
83.91
|
-
|
-
|
91.3
|
-
|
-
|
-
|
-
|
-
|
EBITDA
1 |
-
|
117.3
|
61.4
|
60.47
|
-
|
68.47
|
-
|
-
|
-
|
-
|
-
|
73.9
|
74.91
|
70.25
|
70.18
|
78.13
|
EBIT
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Operating Margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
-
|
-
|
91.43
|
167
|
157.6
|
148.3
|
10.08
|
17
|
9.644
|
11.41
|
-
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
-
|
-
|
111.45%
|
218.63%
|
200.45%
|
183.96%
|
11.16%
|
20.26%
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
EPS
2 |
-
|
-
|
2.960
|
5.280
|
4.950
|
4.590
|
0.2700
|
0.5300
|
0.2600
|
0.3700
|
-2.790
|
0.1089
|
0.1498
|
-0.2216
|
0.3888
|
0.4333
|
Dividend per Share
2 |
-
|
-
|
6.000
|
-
|
-
|
-
|
6.200
|
-
|
-
|
-
|
6.200
|
-
|
-
|
6.200
|
-
|
-
|
Announcement Date
|
7/30/20
|
7/28/21
|
2/24/22
|
4/29/22
|
7/29/22
|
10/28/22
|
2/17/23
|
4/28/23
|
7/28/23
|
10/27/23
|
2/23/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
1,713
|
2,235
|
2,548
|
2,861
|
2,725
|
2,798
|
2,643
|
2,557
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
8.796
x
|
10.54
x
|
10.5
x
|
10.99
x
|
-
|
9.785
x
|
8.939
x
|
8.445
x
|
Free Cash Flow
1 |
169
|
178
|
116
|
95
|
-
|
232
|
245
|
248
|
ROE (net income / shareholders' equity)
|
7.35%
|
7.22%
|
7.3%
|
6.48%
|
6.63%
|
6.73%
|
6.92%
|
6.73%
|
ROA (Net income/ Total Assets)
|
3.88%
|
3.7%
|
3.71%
|
3.43%
|
3.57%
|
3.6%
|
3.65%
|
3.5%
|
Assets
1 |
5,282
|
3,223
|
7,009
|
14,090
|
-1,556
|
1,889
|
9,079
|
9,249
|
Book Value Per Share
2 |
95.00
|
95.30
|
102.0
|
111.0
|
98.60
|
95.00
|
99.60
|
101.0
|
Cash Flow per Share
2 |
6.920
|
6.290
|
6.760
|
6.460
|
-
|
6.450
|
7.080
|
-
|
Capex
1 |
-
|
189
|
84
|
115
|
-
|
255
|
51
|
-
|
Capex / Sales
|
-
|
75.34%
|
28.1%
|
35.4%
|
-
|
72.03%
|
14.03%
|
-
|
Announcement Date
|
2/13/20
|
2/25/21
|
2/24/22
|
2/17/23
|
2/23/24
|
-
|
-
|
-
|
Average target price
72.39
EUR Spread / Average Target +11.36% Consensus |
1st Jan change
|
Capi.
|
---|
| -8.96% | 2.57B | | +6.23% | 57.29B | | -6.12% | 18.92B | | -4.19% | 13.35B | | +2.22% | 7.74B | | -15.50% | 5.68B | | +11.57% | 3.37B | | +0.56% | 3.32B | | -1.49% | 3.21B | | +15.88% | 2.81B |
Healthcare REITs
|